REGN

Regeneron Pharmaceuticals
REGN

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$62.91B
EV
$47.94B
Shares Outstanding
107.02M
Beta
0.44

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$856.75
P/E 2025E
14.70x
P/Revenue 2025E
4.42x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Regeneron Pharmaceuticals, Inc.

gainify
REGN

Regeneron Pharmaceuticals, Inc.

REGN

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; m...

Sector

Healthcare

Industry

Biotechnology

CEO

Schleifer, Leonard

Employees

15,106

IPO Date

1991-04-02

Headquarters

777 Old Saw Mill River Road, Tarrytown, New York, 10591-6707, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved